Clinical Report: Guidelines for Initiating Medications for Opioid Use Disorder

Overview

This report outlines expert consensus on best practices for initiating medications for opioid use disorder (MOUD) in hospital settings, particularly in the context of high-potency synthetic opioids. The findings emphasize the importance of timely MOUD initiation to mitigate overdose risks and improve patient outcomes.

Background

Opioid use disorder (OUD) remains a significant public health crisis, exacerbated by the rise of high-potency synthetic opioids like fentanyl. Hospitalization presents a critical opportunity for initiating MOUD, which can significantly reduce overdose deaths. However, the complexities associated with HPSOs necessitate updated protocols for effective treatment initiation.

Data Highlights

No numerical data available in the provided source material.

Key Findings

• Hospitalization is a pivotal moment for initiating MOUD to reduce overdose deaths.
• High-potency synthetic opioids complicate the initiation of MOUD due to increased withdrawal severity.
• Rapid and high-dose initiation protocols for methadone and buprenorphine are being utilized in practice.
• Expert consensus was developed through a Delphi process involving addiction specialists across the U.S.
• Current practices are largely informed by observational studies rather than randomized clinical trials.

Clinical Implications

Healthcare providers should prioritize the initiation of MOUD during hospitalization, particularly for patients with OUD related to high-potency synthetic opioids. Adopting rapid initiation protocols may improve patient retention and outcomes in this vulnerable population.

Conclusion

The consensus guidelines provide a framework for improving MOUD initiation practices in hospital settings, which is essential for addressing the ongoing opioid crisis effectively.

Related Resources & Content

1. JAMA Network Open, 2023 -- Cost-Effectiveness of the START Hospital Addiction Consultation Service for Opioid Use Disorder Treatment
2. JAMA Network Open, 2023 -- Hospital-Based Management of Opioid Use Disorder in the Fentanyl Era—The Role and Limits of Expert Consensus
3. Intensive Care Medicine, 2023 -- Timed Administration of Intravenous Opioids
4. CDC -- Linking People with Opioid Use Disorder to Medication Treatment | Overdose Prevention
5. Pain Medicine — Diagnosis and coding of opioid misuse: a systematic scoping review and implementation framework
6. Emergency Department–Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial
7. Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine: A Randomized Clinical Trial
8. Linking People with Opioid Use Disorder to Medication Treatment | Overdose Prevention | CDC